Should PrEP Users Switch From Truvada to Descovy?

]]>(MedPage Today) -- At the 2019 Conference on Retroviruses and Opportunistic Infections (CROI) meeting, the DISCOVER trial showed that emtricitabine/tenofovir alafenamide (F/TAF, Descovy) was noninferior to F/tenofovir disoproxil fumarate (TDF...